| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9945862 | The Annals of Thoracic Surgery | 2005 | 6 Pages |
Abstract
We believe this is the first clinical study of low-dose methylprednisolone at an early phase of postoperative ARDS. The beneficial effects of the use of early low-dose steroids in ARDS are consistent with the hypothesis that fibroproliferation is an early response to lung injury, which is inhibited by early low-dose steroid therapy without disturbing operative wound healing.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hyun-Sung MD, Jong Mog MD, Moon Soo MD, Hyae Young MD, PhD, Bin MD, Jae Ill MD, PhD,